Subverted macrophages in the triple-negative breast cancer ecosystem

被引:6
|
作者
Shang, Linxiao [1 ]
Zhong, Yuting [2 ]
Yao, Yan [2 ]
Liu, Cun [3 ]
Wang, Lu [4 ]
Zhang, Wenfeng [5 ]
Liu, Jingyang [2 ]
Wang, Xue [4 ]
Sun, Changgang [6 ,7 ]
机构
[1] Binzhou Med Univ, Sch Integrated Tradit Chinese & Western Med, Yantai 264000, Peoples R China
[2] Shandong Univ Tradit Chinese Med, Coll Clin Med 1, Jinan 250022, Peoples R China
[3] Weifang Med Univ, Coll Tradit Chinese Med, Weifang 261000, Peoples R China
[4] Shandong Univ Tradit Chinese Med, Coll Tradit Chinese Med, Jinan 250022, Peoples R China
[5] Macau Univ Sci & Technol, Sch Tradit Chinese Med, Macau 999078, Peoples R China
[6] Weifang Tradit Chinese Hosp, Dept Oncol, Weifang 261000, Peoples R China
[7] Weifang Tradit Chinese Hosp, Dept Oncol, Weifang, Peoples R China
基金
中国国家自然科学基金;
关键词
Tumor -associated macrophage; Triple-negative breast cancer; Target; Immunosuppression; Subvert; TUMOR-ASSOCIATED MACROPHAGES; MONOCLONAL-ANTIBODY THERAPY; CHECKPOINT BLOCKADE; CELLS; MICROENVIRONMENT; POLARIZATION; RESISTANCE; RECEPTOR; NANOPARTICLES; PHAGOCYTOSIS;
D O I
10.1016/j.biopha.2023.115414
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Tumor-associated macrophages (TAMs) are the most critical effector cells of innate immunity and the most abundant tumor-infiltrating immune cells. They play a key role in the clearance of apoptotic bodies, regulation of inflammation, and tissue repair to maintain homeostasis in vivo. With the progression of triple-negative breast cancer(TNBC), TAMs are "subverted" from tumor-promoting immune cells to tumor-promoting immune suppressor cells, which play a significant role in tumor development and are considered potential targets for cancer therapy. Here, we explored how macrophages, as the most important part of the TNBC ecosystem, are "subverted" to drive cancer evolution and the uniqueness of TAMs in TNBC progression and metastasis. Similarly, we discuss the rationale and available evidence for TAMs as potential targets for TNBC therapy.
引用
收藏
页数:14
相关论文
共 50 条
  • [31] Characteristics of triple-negative breast cancer
    Tim C. de Ruijter
    Jürgen Veeck
    Joep P. J. de Hoon
    Manon van Engeland
    Vivianne C. Tjan-Heijnen
    Journal of Cancer Research and Clinical Oncology, 2011, 137 : 183 - 192
  • [32] Male Triple-Negative Breast Cancer
    Qavi, Qasif
    Alkistawi, Firas
    Kumar, Shashi
    Ahmed, Rizwan
    Al-Zawi, Abdalla Saad Abdalla
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (04)
  • [33] Pharmacotherapy of triple-negative breast cancer
    Arslan, Cagatay
    Dizdar, Omer
    Altundag, Kadri
    EXPERT OPINION ON PHARMACOTHERAPY, 2009, 10 (13) : 2081 - 2093
  • [34] An overview of triple-negative breast cancer
    Kumar, Pankaj
    Aggarwal, Rupali
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2016, 293 (02) : 247 - 269
  • [35] Metastatic Triple-Negative Breast Cancer
    Zhang, Xiaojie
    Yeung, Kay T.
    CURRENT BREAST CANCER REPORTS, 2023, 15 (03) : 288 - 297
  • [36] Immunotherapy for Triple-Negative Breast Cancer
    Cao, Yifeng
    Chen, Chuyang
    Tao, Yi
    Lin, Weifeng
    Wang, Ping
    PHARMACEUTICS, 2021, 13 (12)
  • [37] Targeting Triple-Negative Breast Cancer
    Saljoughian, Manouchehr
    US PHARMACIST, 2020, 45 (10) : 6 - 8
  • [38] Metastatic Triple-Negative Breast Cancer
    Xiaojie Zhang
    Kay T. Yeung
    Current Breast Cancer Reports, 2023, 15 : 288 - 297
  • [39] Immunotherapy in triple-negative breast cancer
    Heather Katz
    Mohamed Alsharedi
    Medical Oncology, 2018, 35
  • [40] Characteristics of triple-negative breast cancer
    de Ruijter, Tim C.
    Veeck, Jurgen
    de Hoon, Joep P. J.
    van Engeland, Manon
    Tjan-Heijnen, Vivianne C.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2011, 137 (02) : 183 - 192